Waters (NYSE:WAT – Get Free Report) announced its earnings results on Tuesday. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.10 by $0.11, Briefing.com reports. Waters had a return on equity of 81.30% and a net margin of 21.72%. The firm had revenue of $636.80 million during the quarter, compared to analysts’ expectations of $635.57 million. During the same quarter in the prior year, the business earned $2.49 earnings per share. The company’s revenue was down 7.0% on a year-over-year basis. Waters updated its Q2 guidance to $2.50-2.60 EPS and its FY24 guidance to $11.75-12.05 EPS.
Waters Stock Performance
Shares of WAT traded up $1.14 during midday trading on Wednesday, reaching $327.20. The stock had a trading volume of 91,412 shares, compared to its average volume of 416,817. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The firm has a 50 day simple moving average of $333.23 and a 200-day simple moving average of $310.76. The firm has a market cap of $19.41 billion, a PE ratio of 30.06, a P/E/G ratio of 6.39 and a beta of 0.98. Waters has a one year low of $231.90 and a one year high of $363.80.
Insiders Place Their Bets
In related news, Director Linda Baddour sold 500 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the sale, the director now owns 2,250 shares in the company, valued at approximately $799,965. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.82% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on WAT
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
- Five stocks we like better than Waters
- Conference Calls and Individual Investors
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- P/E Ratio Calculation: How to Assess Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Stock Splits, Do They Really Impact Investors?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.